These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9986716)
1. Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons. Strumberg D; Pommier Y; Paull K; Jayaraman M; Nagafuji P; Cushman M J Med Chem; 1999 Feb; 42(3):446-57. PubMed ID: 9986716 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids. Fox BM; Xiao X; Antony S; Kohlhagen G; Pommier Y; Staker BL; Stewart L; Cushman M J Med Chem; 2003 Jul; 46(15):3275-82. PubMed ID: 12852757 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors. Cushman M; Jayaraman M; Vroman JA; Fukunaga AK; Fox BM; Kohlhagen G; Strumberg D; Pommier Y J Med Chem; 2000 Oct; 43(20):3688-98. PubMed ID: 11020283 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors. Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138 [TBL] [Abstract][Full Text] [Related]
5. Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity. Antony S; Agama KK; Miao ZH; Hollingshead M; Holbeck SL; Wright MH; Varticovski L; Nagarajan M; Morrell A; Cushman M; Pommier Y Mol Pharmacol; 2006 Sep; 70(3):1109-20. PubMed ID: 16798938 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis. Ioanoviciu A; Antony S; Pommier Y; Staker BL; Stewart L; Cushman M J Med Chem; 2005 Jul; 48(15):4803-14. PubMed ID: 16033260 [TBL] [Abstract][Full Text] [Related]
7. 11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity. Ruchelman AL; Singh SK; Ray A; Wu X; Yang JM; Zhou N; Liu A; Liu LF; LaVoie EJ Bioorg Med Chem; 2004 Feb; 12(4):795-806. PubMed ID: 14759740 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings. Nagarajan M; Morrell A; Fort BC; Meckley MR; Antony S; Kohlhagen G; Pommier Y; Cushman M J Med Chem; 2004 Nov; 47(23):5651-61. PubMed ID: 15509164 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen. Nagarajan M; Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M J Med Chem; 2003 Dec; 46(26):5712-24. PubMed ID: 14667224 [TBL] [Abstract][Full Text] [Related]
10. Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison. Antony S; Kohlhagen G; Agama K; Jayaraman M; Cao S; Durrani FA; Rustum YM; Cushman M; Pommier Y Mol Pharmacol; 2005 Feb; 67(2):523-30. PubMed ID: 15531731 [TBL] [Abstract][Full Text] [Related]
11. Syntheses and biological evaluation of topoisomerase I-targeting agents related to 11-[2-(N,N-dimethylamino)ethyl]-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-one (ARC-31). Satyanarayana M; Feng W; Cheng L; Liu AA; Tsai YC; Liu LF; LaVoie EJ Bioorg Med Chem; 2008 Aug; 16(16):7824-31. PubMed ID: 18676151 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay. Morrell A; Jayaraman M; Nagarajan M; Fox BM; Meckley MR; Ioanoviciu A; Pommier Y; Antony S; Hollingshead M; Cushman M Bioorg Med Chem Lett; 2006 Aug; 16(16):4395-9. PubMed ID: 16750365 [TBL] [Abstract][Full Text] [Related]
13. On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex. Xiao X; Antony S; Pommier Y; Cushman M J Med Chem; 2005 May; 48(9):3231-8. PubMed ID: 15857129 [TBL] [Abstract][Full Text] [Related]
14. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I. Antony S; Jayaraman M; Laco G; Kohlhagen G; Kohn KW; Cushman M; Pommier Y Cancer Res; 2003 Nov; 63(21):7428-35. PubMed ID: 14612542 [TBL] [Abstract][Full Text] [Related]
15. Novel autoxidative cleavage reaction of 9-fluoredenes discovered during synthesis of a potential DNA-threading indenoisoquinoline. Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M J Org Chem; 2004 Oct; 69(22):7495-501. PubMed ID: 15497974 [TBL] [Abstract][Full Text] [Related]
16. Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity. Ruchelman AL; Zhu S; Zhou N; Liu A; Liu LF; LaVoie EJ Bioorg Med Chem Lett; 2004 Nov; 14(22):5585-9. PubMed ID: 15482929 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitors. Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M Bioorg Med Chem; 2004 Oct; 12(19):5147-60. PubMed ID: 15351398 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model. Jayaraman M; Fox BM; Hollingshead M; Kohlhagen G; Pommier Y; Cushman M J Med Chem; 2002 Jan; 45(1):242-9. PubMed ID: 11754595 [TBL] [Abstract][Full Text] [Related]
19. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517. Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891 [TBL] [Abstract][Full Text] [Related]